Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC - PubMed (original) (raw)
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
H Donis-Keller et al. Hum Mol Genet. 1993 Jul.
Abstract
Multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid carcinoma (FMTC) are dominantly inherited conditions which predispose to the development of endocrine neoplasia. Evidence is presented that sequence changes within the coding region of the RET proto-oncogene, a putative transmembrane tyrosine kinase, may be responsible for the development of neoplasia in these inherited disorders. Single strand conformational variants (SSCVs) in exons 7 and 8 of the RET proto-oncogene were identified in eight MEN 2A and four FMTC families. The variants were observed only in the DNA of individuals who were either affected or who had inherited the MEN2A or FMTC allele as determined by haplotyping experiments. The seven variants identified were sequenced directly. All involved point mutations within codons specifying cysteine residues, resulting in nonconservative amino acid changes. Six of the seven mutations are located in exon 7. A single mutation was found in exon 8. Variants were not detected in four MEN 2B families studied for all exon assays available, nor were they detectable in 16 cases of well documented sporadic medullary thyroid carcinoma or pheochromocytoma that were tested for exon 7 variants. Coinheritance of the mutations with disease and the physical and genetic proximity of the RET proto-oncogene provide evidence that RET is responsible for at least two of the three inherited forms of MEN 2. Neither the normal function, nor the ligand of RET are yet known. However, its apparent involvement in the development of these inherited forms of neoplasia as well as in papillary thyroid carcinoma suggest an important developmental or cell regulatory role for the protein.
Similar articles
- A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JW, van Amstel HK, Romeo G, et al. Hofstra RM, et al. Nature. 1994 Jan 27;367(6461):375-6. doi: 10.1038/367375a0. Nature. 1994. PMID: 7906866 - [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G, Domené HM, Iorcansky S, Barontini M. Sansó G, et al. Medicina (B Aires). 1998;58(2):179-84. Medicina (B Aires). 1998. PMID: 9706252 Spanish. - RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ, Mulligan LM, Eng C. Marsh DJ, et al. Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461. Horm Res. 1997. PMID: 9167949 Review. - [Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)].
Komminoth P, Muletta-Feurer S, Soltermann A, Gemsenjäger E, Bürgi H, Staub JJ, Schönle E, Fried M, Vetter W, Spinas GA, Heitz PU. Komminoth P, et al. Schweiz Med Wochenschr. 1996 Aug 6;126(31-32):1329-38. Schweiz Med Wochenschr. 1996. PMID: 8765374 Review. German.
Cited by
- Medullary thyroid carcinoma--update and present management controversies.
Al-Rawi M, Wheeler MH. Al-Rawi M, et al. Ann R Coll Surg Engl. 2006 Sep;88(5):433-8. doi: 10.1308/003588406X117043. Ann R Coll Surg Engl. 2006. PMID: 17002842 Free PMC article. Review. - Medullary thyroid cancer: RET testing of an archival material.
Godballe C, Jørgensen G, Gerdes AM, Krogdahl AS, Tybjaerg-Hansen A, Nielsen FC. Godballe C, et al. Eur Arch Otorhinolaryngol. 2010 Apr;267(4):613-7. doi: 10.1007/s00405-009-1115-4. Epub 2009 Oct 13. Eur Arch Otorhinolaryngol. 2010. PMID: 19823860 - Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue.
Bounacer A, Du Villard JA, Wicker R, Caillou B, Schlumberger M, Sarasin A, Suárez HG. Bounacer A, et al. Br J Cancer. 2002 Jun 17;86(12):1929-36. doi: 10.1038/sj.bjc.6600371. Br J Cancer. 2002. PMID: 12085189 Free PMC article. - Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.
Peixoto Callejo I, Américo Brito J, Zagalo CM, Rosa Santos J. Peixoto Callejo I, et al. Clin Transl Oncol. 2006 Jun;8(6):435-43. doi: 10.1007/s12094-006-0198-2. Clin Transl Oncol. 2006. PMID: 16790397 - Multiple endocrine neoplasia type 2.
Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Tognarini I, Luzi E, Brandi ML. Marini F, et al. Orphanet J Rare Dis. 2006 Nov 14;1:45. doi: 10.1186/1750-1172-1-45. Orphanet J Rare Dis. 2006. PMID: 17105651 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases